Today: 8 February 2026
Subscribe
Browse Category

Stock Market News 9 January 2026

UWMC stock jumps on Trump’s $200 billion mortgage-bond order as traders hunt for proof rates will fall

UWMC stock jumps on Trump’s $200 billion mortgage-bond order as traders hunt for proof rates will fall

UWM Holdings shares surged 14% to $5.36 Friday after President Trump ordered $200 billion in mortgage-bond purchases to lower borrowing costs. Over 22 million shares traded. CEO Mat Ishbia’s SFS Holding sold nearly 1.9 million shares earlier in the week at $4.43–$4.70. Investors await inflation and mortgage-rate data for further direction.
9 January 2026
··
AbbVie stock slips on $1.3B charge, deal-rumor denial — what’s next for ABBV

AbbVie stock slips on $1.3B charge, deal-rumor denial — what’s next for ABBV

AbbVie shares fell 0.8% to $222.35 after the company cut its 2025 profit outlook and denied takeover talks with Revolution Medicines. AbbVie now expects fourth-quarter adjusted EPS of $2.61–$2.65, down from $3.32–$3.36, citing a $1.3 billion pre-tax acquired R&D expense. Wolfe Research downgraded the stock to “Peer Perform.” AbbVie said results for the quarter ended Dec. 31 are not yet final.
9 January 2026
··
Ford stock slips today after Piper upgrade pop as investors weigh Ford’s “eyes-off” driving push

Ford stock slips today after Piper upgrade pop as investors weigh Ford’s “eyes-off” driving push

Ford shares dropped 1.5% to $14.19 Friday, retracing gains from Thursday’s Piper Sandler upgrade. Traders are watching for Ford’s Feb. 10 earnings, with focus on EV spending and software revenue. The company plans to launch Level 3 driver-assist in 2028, but pricing and rollout details remain undecided. Broader market sentiment was shaped by a weaker U.S. jobs report and rate cut speculation.
9 January 2026
···
Oklo stock jumps as Meta backs 1.2-GW Ohio nuclear power campus for AI data centers

Oklo stock jumps as Meta backs 1.2-GW Ohio nuclear power campus for AI data centers

Oklo shares jumped 11% after announcing a deal with Meta to develop a 1.2-gigawatt nuclear campus in Ohio. Meta also signed long-term nuclear power agreements with Vistra and TerraPower as AI drives up electricity demand. Investors are watching for updates on permits, funding, and Oklo’s next quarterly report. Trading volume in Oklo surged to 22.1 million shares.
9 January 2026
···
Northrop Grumman stock jumps 4% as Trump payout order shakes defense sector, new contracts land

Northrop Grumman stock jumps 4% as Trump payout order shakes defense sector, new contracts land

Northrop Grumman shares climbed 4.2% to $615.86 Friday, rebounding after a sharp drop earlier in the week triggered by Trump’s order tying dividends, buybacks, and executive pay to weapons delivery schedules. The company announced a $94.3 million Navy missile contract and a $231.5 million Marine Corps drone award. Defense stocks have swung on policy signals and new contract wins.
9 January 2026
··
Vistra stock jumps after Meta signs 20-year nuclear power deal — what’s driving VST today

Vistra stock jumps after Meta signs 20-year nuclear power deal — what’s driving VST today

Vistra Corp shares jumped 11.4% to $167.81 after announcing 20-year nuclear power purchase agreements with Meta Platforms covering over 2,600 MW from three plants. The contracts begin deliveries in late 2026 and could boost Vistra’s adjusted free cash flow by up to 17% once fully in place. Meta also signed nuclear deals with two other firms. Vistra stock remains below its September high of $219.82.
9 January 2026
······
Lockheed Martin stock jumps as Trump order targets defense buybacks and dividends; earnings next

Lockheed Martin stock jumps as Trump order targets defense buybacks and dividends; earnings next

Lockheed Martin shares rose 4.2% to $539.96 Friday after President Trump signed an executive order tying dividends, buybacks, and executive pay to weapons delivery schedules. Defense stocks gained as Trump called for a $1.5 trillion 2027 military budget, far above the $901 billion set for 2026. Lockheed paid $2.3 billion each in dividends and buybacks last year. The company reports quarterly results Jan. 29.
9 January 2026
···
Gabion Technologies IPO allotment today: How to check status as 768x demand puts SME listing in focus

Gabion Technologies IPO allotment today: How to check status as 768x demand puts SME listing in focus

Gabion Technologies India’s IPO share allotment is set for Jan. 9 after the offer drew 768 times subscription, with retail and non-institutional investors leading demand, BSE data showed. Shares are scheduled to list Jan. 13 on the BSE SME platform. Grey market prices hovered near 113 rupees, about 40% above the issue price, though this market is unregulated. The IPO was a fresh issue of 3.6 million shares at 76–81 rupees each.
9 January 2026
··
Why Opendoor stock is jumping today: Trump’s $200 billion mortgage-bond buy order

Why Opendoor stock is jumping today: Trump’s $200 billion mortgage-bond buy order

Opendoor shares jumped 20.5% to $7.75 in late morning trading Friday, with volume topping 90 million, after President Trump ordered $200 billion in mortgage-bond purchases. Other housing stocks also rallied. Investors await details on the bond-buying plan and Opendoor’s next earnings report, set for Feb. 26. Vanguard disclosed owning 11.62% of Opendoor as of Dec. 31.
9 January 2026
··
Westlake (WLK) stock steadies near $80 after a 7% jump as analysts reset targets

Westlake (WLK) stock steadies near $80 after a 7% jump as analysts reset targets

Westlake shares rose 0.8% to $80.20 Friday, extending Thursday’s 6.8% surge after the company closed its purchase of ACI/Perplastic’s compounding businesses. Mizuho raised its price target to $88, while BofA cut its target to $82 but kept a buy rating. The stock traded between $78.49 and $81.19. Investors are awaiting late-February earnings for signals on 2026 demand and pricing.
9 January 2026
·
Robinhood stock edges higher after Argus starts coverage; CEO share sale filing hangs over

Robinhood stock edges higher after Argus starts coverage; CEO share sale filing hangs over

Robinhood shares rose 0.6% to $116.10 Friday after Argus began coverage with a buy rating and $145 price target. CEO Vladimir Tenev sold 375,000 shares this week for about $45.6 million under a prearranged plan, according to a regulatory filing. Barclays trimmed its target to $159 but kept an “overweight” call. A legal brief from Native American groups targeted Robinhood’s prediction market business.
9 January 2026
·
Figure Technology Solutions stock slips after a $62 target hike — what traders watch nextFigureFigure Technology Solutions stock slips after a $62 target hike — what traders watch next

Figure Technology Solutions stock slips after a $62 target hike — what traders watch nextFigureFigure Technology Solutions stock slips after a $62 target hike — what traders watch next

Figure Technology Solutions shares fell 1.5% to $57.50 Friday, easing after a recent price target hike from Keefe, Bruyette & Woods. The stock is up 43% year-to-date and is set to report earnings Feb. 12, with analysts expecting 16 cents per share. FIGR last posted 34 cents per share on $156.37 million revenue in November. Broader fintech and crypto stocks traded mixed.
9 January 2026
·
Exxon Mobil (XOM) stock ticks up as filing flags up to $1.2 bln Q4 upstream hit

Exxon Mobil (XOM) stock ticks up as filing flags up to $1.2 bln Q4 upstream hit

Exxon Mobil shares rose 0.6% to $123.63 after warning lower crude prices may cut Q4 upstream earnings by $800 million to $1.2 billion, partly offset by stronger refining margins. Chevron gained 1.4% as oil prices climbed on supply concerns. Exxon also signed a memorandum with Turkey’s TPAO for exploration in the Black Sea and Mediterranean. Investors await Exxon’s Q4 results on Jan. 30.
9 January 2026
···
CG Oncology stock jumps 25% after pulling Phase 3 PIVOT-006 bladder cancer data into 1H 2026

CG Oncology stock jumps 25% after pulling Phase 3 PIVOT-006 bladder cancer data into 1H 2026

CG Oncology shares surged 25.1% to $52.45 after the company advanced the expected release of late-stage bladder cancer trial results to the first half of 2026. The PIVOT-006 Phase 3 trial enrolled over 360 patients and compares cretostimogene grenadenorepvec to surveillance after tumor removal. Trading volume topped 4.1 million shares by midday. Morgan Stanley raised its price target on the stock to $89.
9 January 2026
···
Rocket Lab stock jumps today despite $103 million CFO sale filing: what RKLB traders watch next

Rocket Lab stock jumps today despite $103 million CFO sale filing: what RKLB traders watch next

Rocket Lab shares climbed 4.6% to $86.87 Friday morning after SEC filings showed CFO Adam Spice sold $103.1 million in stock and COO Frank Klein sold $7.3 million, both under preset 10b5-1 plans. Shares had dropped 1.2% Thursday following the insider sales. Investors are watching for the next earnings update and any changes to the Neutron rocket timetable.
9 January 2026
··
1 … 421 422 423 424 425 … 1,179

Stock Market Today

RELX share price slides again on AI worries; what to watch ahead of Feb 12 results

RELX share price slides again on AI worries; what to watch ahead of Feb 12 results

8 February 2026
RELX shares fell 4.6% to 2,145p on Friday, near a 52-week low, despite the FTSE 100 closing higher. The company disclosed a new buyback of 465,361 shares on Feb. 6 and has repurchased over 8.8 million shares since Jan. 2. Investors await RELX’s full-year 2025 results on Feb. 12 amid concerns over AI’s impact on its core business.
Glencore shares steady after Rio walks away — what to watch before Monday’s trade

Glencore shares steady after Rio walks away — what to watch before Monday’s trade

8 February 2026
Glencore shares closed up 0.6% at 478.10 pence Friday after Rio Tinto ended merger talks, issuing a “no intention to bid” statement. Glencore’s board rejected the proposed deal terms, citing concerns over valuation and governance. Attention now turns to possible asset sales, including its $5 billion Kazzinc stake, ahead of Glencore’s annual results on Feb. 18.
Go toTop